Spero Therapeutics (NASDAQ:SPRO) is preparing to release its quarterly earnings on Thursday, 2024-11-14. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect Spero Therapeutics to report an earnings per share (EPS) of $-0.50. The announcement from Spero Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter. It’s worth noting for new investors that guidance can be a key determinant of stock price movements. Past Earnings PerformanceLast quarter the company beat EPS by…